Vertex Pharmaceuticals (VRTX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 2 |
Ownership rank: | 356 |
% of all portfolios: | 0.033% |
Hold Price * : | $466.42 |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q2  2024 | |||||
≡ | Torray Funds | Add 0.28% | 39 | 0.00 | |
Q4  2023 | |||||
≡ | Torray Funds | Buy | 14,068 | 0.93 | |
Q3  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 1,457 | 0.01 | |
Q4  2021 | |||||
≡ | Tweedy Browne Co. - Tweedy Browne Value Fund | Buy | 23,825 | 1.26 | |
Q3  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 18,052 | 0.04 | |
Q1  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 6,254 | 0.01 | |
Q1  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 460 | 0.00 | |
Q1  2015 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 524,867 | 1.00 | |
Q1  2009 | |||||
≡ | Bill & Melinda Gates Foundation Trust | Buy | 95,000 | 0.03 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.